miR-1247-3p mediates apoptosis of cerebral neurons by targeting caspase-2 in stroke
•miR-1247-3p can mediate apoptosis of neuronal in stroke.•Caspase-2 may be a target of miR-1247-3p.•Caspase-2 is involved in the apoptosis of neuronal induced by stroke.•MRTF-A can regulate miR-1247-3P expression. Brain stroke is one of the leading causes of death worldwide. We explored a potential...
Gespeichert in:
Veröffentlicht in: | Brain research 2019-07, Vol.1714, p.18-26 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •miR-1247-3p can mediate apoptosis of neuronal in stroke.•Caspase-2 may be a target of miR-1247-3p.•Caspase-2 is involved in the apoptosis of neuronal induced by stroke.•MRTF-A can regulate miR-1247-3P expression.
Brain stroke is one of the leading causes of death worldwide. We explored a potential stroke-related role for a newly found microRNA, miR-1247-3p, and one of its target genes, caspase-2, predicted by TargetScanVert. In the present study, we found that miR-1247-3p was downregulated during ischemia/reperfusion (I/R) and that LV-miR-1247-3p overexpression attenuated brain impairment induced by I/R. Similar results were observed in neuro2a (N2a) cells treated with oxygen-glucose deprivation/reoxygenation (OGD/R). Caspase-2 was upregulated in the I/R and OGD/R model, while Z-VDVAD-FMK – the inhibitor of caspase-2-inhibited apoptosis of N2a cells induced by OGD/R. An miR-1247-3p mimic inhibited caspase-2 expression and attenuated apoptosis of N2a cells induced by OGD/R. Myocardin-related transcription factor-A (MRTF-A) overexpression upregulated miR-1247 and mature miR-1247-3p levels and attenuated apoptosis induced by OGD/R, whereas its anti-apoptotic function could be blocked by a miR-1247-3p inhibitor. Hence, we conclude that miR-1247-3p may protect cells during brain stroke. This study offers insights for the development of effective therapeutics for promoting the survival of cerebral neurons during brain I/R injury. |
---|---|
ISSN: | 0006-8993 1872-6240 |
DOI: | 10.1016/j.brainres.2019.02.020 |